The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | Content | |
|---|---|---|---|
| 1/04/2026 | On corporate transactions | ROVI announces the closing of the Asset Purchase Agreement entered into in September 2025 for the acquisition of a pharmaceutical manufacturing facility in Phoenix, Arizona (USA) | |
| 25/02/2026 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2025 annual report regarding remuneration of the members of the Board of Directors. | |
| 25/02/2026 | Annual Corporate Governance Report | The Company submits the Annual Corporate Governance Report for fiscal year 2025. | |
| 25/02/2026 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors. | |
| 25/02/2026 | On P&L | The Company releases the full year 2025 financial results presentation. | |
| 25/02/2026 | On P&L | The Company releases the press release related to the full year 2025 financial results. |